1. Recognition and management of common, rare, and novel serum protein electrophoresis and immunofixation interferences;McCudden,2018
2. Therapeutic monoclonal antibody interference in monoclonal gammopathy monitoring: a denosumab experience;Aydin,2023
3. Tixagevimab plus cilgavimab does not affect the interpretation of electrophoretic and free light chain assays;Baloda,2023
4. Burden of disease of COVID-19: strengthening the collaboration for national studies;Pires,2022
5. Intramuscular AZD7442 (tixagevimab-cilgavimab) for prevention of Covid-19;Levin,2022